Thromb Haemost 1975; 34(01): 181-193
DOI: 10.1055/s-0038-1651366
Original Article
Schattauer GmbH

Disseminated Intravascular Coagulation

Experience in a Major Cancer Center
Hamid Al-Mondhiry*
1   Hematology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, and the Department of Medicine, Cornell University Medical College, New York, N. Y.
› Author Affiliations
Further Information

Publication History

Received 17 December 1974

Accepted 10 March 1975

Publication Date:
02 July 2018 (online)

Summary

Review of the coagulation laboratory records and medical records at Memorial Sloan-Kettering Cancer Center over a three year period (1971-1974) revealed 89 patients with disseminated intravascular coagulation (DIC). The diagnosis of DIC was made if laboratory studies showed evidence of quantitative and qualitative changes in fibrinogen and significant thrombocytopenia. The patients included 19 with leukemia (17 acute), 3 with multiple myeloma, 15 with lymphoma, 46 with metastatic solid tumors, (10 lung, 9 breast, 8 gastrointestinal, 12 genitourinary, 7 miscellaneous) 4 with vascular tumors, and 3 without tumor. Other conditions which might have precipitated or initiated DIC such as gram-negative sepsis, liver impairment, or mucin secreting tumors were present in the majority of patients. Bleeding occurred in 75% of the patients and was fatal in 36%. Thromboembolism occurred in 22.5%. Thirteen percent were asymptomatic. Serum lactic dehydrogenase was elevated in over 75 % of the patients at the time of, or subsequent to the occurrence of DIC. Treatment with heparin was helpful in only three of twenty patients. Eighty percent of the patients died within one to over 30 days of the onset of DIC. Post mortem evidence of DIC was present in 18 of 43 autopsies. Results of this study indicate that DIC is a frequent complication of a wide variety of tumors and that its occurrence causes morbidity and mortality in a significant number of patients. Treatment with heparin is of little help unless remission is induced and the precipitating factor(s) are reversed.

* Present address to which reprint requests should be addressed : Medical City, Baghdad, Iraq.


 
  • References

  • 1 Bettigole R. E. et al. 1970; Hypofibrinogenemia due to L - asparaginase : Studies on fibrinogen survival using autologous 131 VI-fibrinogen. Blood 35: 195.
  • 2 Biggs R. 1972. Human blood coagulation, Hemostasis and Thrombosis. Oxford; Blackwell Scientific Publications: 614.
  • 3 Brodsky I, and Siegal N. H. 1970; The diagnosis and treatment of disseminated intravascular coagulation. Medical Clinics of North America 54: 555.
  • 4 Colman R. W. et al. 1972; Disseminated intravascular coagulation: An approach. American Journal of Medicine 52: 679.
  • 5 Corrigan J. J. et al. 1973; Disseminated intravascular coagulation in septic shock -Report of three cases not treated with heparin. American Journal of Diseases of Childhood 126: 629.
  • 6 Corrigan Jr. J. J, and Jordan D. M. 1970; Heparin therapy in septicemia with disseminated intravascular coagulation : Effect on mortality and in correction of hemostatic defects. New England Journal of Medicine 283: 778.
  • 7 Degnan T. J. et al. 1972; Small transfusion, severe reaction. Annals of Internal Medicine 78: 452.
  • 8 Funk C. et al. 1971; Reptilase-R, A new reagent in blood coagulation. British Journal of Hematology 21: 43.
  • 9 Goodnight S. H. 1974; Bleeding and intravascular clotting in malignancy: A review. Annals of the New York Academy of Sciences 230: 271.
  • 10 Hawiger J. et al. 1970; Measurement of fibrinogen and fibrin degradation products in serum by staphylococcal clumping test. Journal of Laboratory and Clinical Medicine 75: 93.
  • 11 Kasabach H. H, and Merritt K. K. 1940; Capillary hemangioma with extensive purpura. American Journal of Diseases of Childhood 59: 1603.
  • 12 Kuffer F. R. et al. 1968; Klippel-Trenaunay Syndrome, Visceral angiomatosis and thrombocytopenia. Journal of Pediatric Surgery 3: 65.
  • 13 Langdell R. D. et al. 1953; Effect of antihemophiliac factor on one stage clotting tests. Journal of Laboratory and Clinical Medicine 41: 637.
  • 14 Leavelle D. E. et al. 1971; Staphylococcal clumping on a microtiter plate. American Journal of Clinical Pathology 55: 452.
  • 15 Leavy R. A. et al. 1970; Disseminated intravascular coagulation. A complication of chemotherapy in acute myelomonocytic leukemia. Cancer 26: 142.
  • 16 McFarlane A. S. 1963; In vivo behaviour 131 -fibrinogen. Journal of Clinical Investigation 42: 346.
  • 17 McKay D. G. 1970; Progress in disseminated intravascular coagulation and fibrinolysis. California Medicine III 186: 279.
  • 18 McKay D. G, and Müller-Berghaits G. 1967; Therapeutic implications of disseminated intravascular coagulation. American Journal of Cardiology 20: 392.
  • 19 Mehta B. et al. 1972; Disseminated intravascular coagulation following cardiac arrest: A study of 15 patients. American Journal of Medical Sciences 264: 353.
  • 20 Meeskey C. et al. 1967; Defibrination syndrome: Clinical features and laboratory diagnosis. British Journal of Hematology 13: 528.
  • 21 Mersky C. 1973; Defibrination Syndrome or. . . Blood 41: 599.
  • 22 Peck S. D, and Reiquam C. W. 1973; Disseminated intravascular coagulation in cancer patients: Supportive evidence. Cancer 5: 1114.
  • 23 Pineo G. F. et al. 1974; Tumor, mucous production, and hypercoagulability. Annals of the New York Academy of Sciences 230: 262.
  • 24 Preston F. E. et al. 1973; Intravascular coagulation and E-coli septicemia. Journal of Clinical Pathology 26: 120.
  • 25 Quick A. J. 1945; On the quantitative estimation of prothrombin. American Journal of Clinical Pathology 15: 566.
  • 26 Robboy S. J. et al. 1973; Pulmonary hemorrhage syndrome as a manifestation of disseminated intravascular coagulation: Analysis of ten cases. Chest 63: 718.
  • 27 Sherry S. et al. 1959; Studies on enhanced fibrinolytic activity in man. Journal of Clinical Investigation 38: 810.
  • 28 Stirland R. M. 1956; A rapid method of estimating fibrinogen. Lancet 1: 672.
  • 29 Thomas D. P. et al. 1970; A comparative study of four methods for detecting fibrinogen degradation products in sera from patients with various diseases. New England Journal of Medicine 283: 663.
  • 30 Watson D. 1961; Rapid estimation of fibrinogen. British Medical Journal 1: 903.
  • 31 Weiss H. J. et al. 1972; Fatal disseminated intravascular coagulation and hemolytic anemia following stibophen therapy. American Journal of Medical Sciences 264: 375.